On October 2nd, 2018 Fierce Biotech disclosed the 15 selected companies for the Fierce 15 Award. This prestigious award has come to symbolize novelty and being at the forefront of biotechnology development among privately held businesses. The winners of this award are aiming at breakthroughs and big things, not at being ‘me-too’.
Since 2010 1stOncology has included the Fierce 15 award in a set of attractive benchmarking parameters to identify and analyze the pipeline of movers and shakers in cancer drug development. Year after year oncology keeps coming back as a dominating therapeutic area among the Fierce 15 awardees and 2018 is no different!
In fact, no less than eleven out of the fifteen 2018 Fierce 15 companies are active in cancer drug development. Three of the companies, Beam Therapeutics, Gossamer Bio and Quentis Therapeutics were all founded in 2018, with another three companies formed in 2017, see table below. Compass Therapeutics is this year oldest recipient founded in 2013.
Fierce pointed to the fact that this years winners have been notable in their success in already raising serious funding. In total they have raised $1.36 billion in funding rounds and capital commitments with four over $100 million and most others between $40 million and $60 million. Notable too was that all eleven of the oncology companies were based out of the US, whereas in previous years the field has been more global.
Our 1stOncology clients can review detailed pipeline analysis of each these Fierce 15 companies via our special analyst report available in the platform. For all others, we are happy to offer a free online demo here, so you can see the actionable information that 1stOncology provides.
List of Oncology Associated Companies Among this Year Recipients of the Fierce 15 Award:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!